MedPath
HSA Approval

RECTOGESIC OINTMENT 0.2% w/w

SIN12240P

RECTOGESIC OINTMENT 0.2% w/w

RECTOGESIC OINTMENT 0.2% w/w

March 27, 2003

STEWARD CROSS PTE LTD

STEWARD CROSS PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSTEWARD CROSS PTE LTD
Licence HolderSTEWARD CROSS PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

OINTMENT

**DOSAGE AND ADMINISTRATION** _Adults_ Insert a 1 to 1.5 cm strip of ointment (see measurement on box) into the anal canal, either with the finger or an applicator. Apply the ointment 3 times daily and do not exceed this dosage. Close the tube tightly, immediately after each use. _Use in children_ Safety and effectiveness in children have not been established.

TOPICAL

Medical Information

**INDICATIONS** For the treatment of anal fissure and relief of the symptoms associated with anal fissure.

**CONTRAINDICATIONS** Severe anaemia, glaucoma, pregnancy, lactation, hypotension, increased intracranial pressure and idiosyncrasy to glyceryl trinitrate. Glyceryl trinitrate should not be coadministered with Viagra™ (sildenafil citrate) and/or other Phosphodiesterase Type 5 (PDE5) Inhibitors as this may potentiate the hypotensive effects of organic nitrates.

C05AE01

glyceryl trinitrate

Manufacturer Information

STEWARD CROSS PTE LTD

Mayne Pharma International Pty Ltd

Active Ingredients

GLYCERYL TRINITRATE

0.2% w/w

Nitroglycerin

Documents

Package Inserts

RECTOGESIC OINTMENT 0.2% PI.pdf

Approved: July 1, 2021

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

RECTOGESIC OINTMENT 0.2% w/w - HSA Approval | MedPath